Search Results 1261-1270 of 11233 for Antifungal Resistance

  1. Antiphospholipid syndrome - Doctors and departments - Mayo Clinic

    Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.

  2. A Study Evaluating Tolerability And Efficacy Of Navitoclax In Combination With Ruxolitinib In Subjects With Myelofibrosis - Mayo Clinic

    Ongoing systemic infection (viral, bacterial, or fungal);; Febrile neutropenia. Subject has received any of the following within 14 days prior to the first ...

  3. Mycobacterium Avium Complex Pulmonary Infections Systems Biology to Predict Progression and Treatment - Mayo Clinic

    Patients diagnosed with concomitant severe pulmonary infection with other pathogen(s) including bacterial empyema or fungal infections. Refractory cough ...

  4. Biologic Therapy - Mayo Clinic Healthcare

    Biological treatments help manage autoimmune and inflammatory conditions. Mayo Clinic Healthcare provides specialist assessment and personalised biologic ...

  5. Clinical trials - Oncology (Medical)

    ... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...

  6. Efficacy And Safety Of Seralutinib In Adult Subjects With PAH - Mayo Clinic

    Pulmonary vascular resistance (PVR) ≥ 400 dyne·s/cm^5; AND; Pulmonary capillary wedge pressure (PCWP) or left ventricle end-diastolic pressure (LVEDP) ≤ 12 ...

  7. A Second Trial Of The Abbreviated Protocol Two-Stage Exchange - Mayo Clinic

    Patients with a fungal PJI as determined by one or more positive fluid and/or tissue cultures. Patients who have a skeletal defect greater than 150 mm in ...

  8. Drugs and Supplements that Start with G - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...

  9. Testing The Addition Of M3814 (Peposertib) To Radiation Therapy For Patients With Advanced Head And Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

    ... antifungals) -Pregnancy and nursing females, if applicable -Concomitant use of proton pump inhibitors (or unable to stop 5 days prior to treatment) -Receipt ...

  10. A Study To Assess The Efficacy And Safety Of Efgartigimod IV In Adult Participants With Primary Immune Thrombocytopenia - Mayo Clinic

    After an up to 2 weeks screening period, eligible participants will be randomized in a 2:1 ratio to receive either efgartigimod IV or placebo IV, respectively ...